News for Ontrak Inc (HY1N.BE)

NEW YORK, March 5, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead

/PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a...

Selloffs feel horrible, but they don’t often last lonG, even the bad ones. The S&P 500 Index has corrected at least 4% on 19 occasions.

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action ...

NEW YORK, March 04, 2021 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Ontrak, Inc. in the United States District Court for the Central...

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Ontrak, Inc. ...

NEW YORK, March 4, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating securities fraud cla...

Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating securities fraud claims on behalf of shareholders of Ontrak, Inc. ("Ontrak" or the "Company") (NASDAQ: OTRK) resulting from allegations that Ontrak might have issued misleading information to the investing public.

Glancy Prongay & Murray LLP ("GPM") announces that it has filed a class action lawsuit in the United States District Court for the Central District of

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ontrak, Inc. OTRK on behalf of

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.95%